Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5800
-0.0300 (-4.92%)
Mar 31, 2025, 9:51 AM EDT - Market open

Harvard Bioscience Stock Forecast

HBIO's stock price has decreased by -85.48% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Harvard Bioscience stock has a target of 4.50, which predicts an increase of 675.86% from the current stock price of 0.58.

Analyst Consensus: Buy
Target Low Average Median High
Price $4.50 $4.50 $4.50 $4.50
Change +675.86% +675.86% +675.86% +675.86%

Analyst Ratings

According to 1 stock analyst, the rating for Harvard Bioscience is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 111110
Buy 222221
Hold 000000
Sell 000000
Strong Sell 000000
Total 333331

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Buy
Maintains
$5.5$4.5
Buy Maintains $5.5$4.5 +675.86% Mar 24, 2025
Benchmark
Benchmark
Buy
Reiterates
$7
Buy Reiterates $7 +1,106.90% Jun 22, 2023
Benchmark
Benchmark
Strong Buy
Maintains
$4$7
Strong Buy Maintains $4$7 +1,106.90% Apr 26, 2023
Keybanc
Keybanc
Buy
Maintains
$5$7
Buy Maintains $5$7 +1,106.90% Apr 26, 2023
Benchmark
Benchmark
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +589.66% Mar 10, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
99.76M
from 94.14M
Increased by 5.97%
Revenue Next Year
114.24M
from 99.76M
Increased by 14.52%
EPS This Year
0.13
from -0.28
EPS Next Year
0.26
from 0.13
Increased by 100.00%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
102.10M118.90M113.34M112.25M94.14M99.76M114.24M
Revenue Growth
-12.12%16.46%-4.68%-0.96%-16.14%5.97%14.52%
EPS
-0.20-0.01-0.23-0.08-0.280.130.26
EPS Growth
------100.00%
Forward PE
-----4.552.27
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 103.7M 117.6M
Avg 99.8M 114.2M
Low 94.9M 109.8M

Revenue Growth

Revenue Growth 20252026
High
10.2%
17.9%
Avg
6.0%
14.5%
Low
0.8%
10.0%

EPS Forecast

EPS 20252026
High 0.19 0.26
Avg 0.13 0.26
Low 0.07 0.25

EPS Growth

EPS Growth 20252026
High -
105.9%
Avg -
100.0%
Low -
92.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.